Efficacy of gc therapy for the patient of itnbc with resistance to TAC therapy

研究成果: Contribution to journalArticle査読

抄録

We report a case of TNBC treated effectively with a platinum-based regimen after developing resistance to anthracycline and taxane-based neoadjuvant chemotherapy (NAC). A 59-year-old woman with a right breast mass and high fever visited our clinic and was diagnosed as having inflammatory triple negative breast cancer (iTNBC). She was treated with NAC of docetaxel, doxorubicin, and cyclophosphamide (TAC) using pegf ilgrastim. After 5 courses of TAC, the therapy failed and the disease progressed. Thus, a combination regimen of gemcitabine and carboplatin (GC) was administered. The treatment was successful, and the patient underwent a curative operation after 6 courses of the GC therapy.

本文言語英語
ページ(範囲)703-705
ページ数3
ジャーナルJapanese Journal of Cancer and Chemotherapy
44
8
出版ステータス出版済み - 8 2017

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Efficacy of gc therapy for the patient of itnbc with resistance to TAC therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル